Medicine and Dentistry
Liver Cirrhosis
94%
Colonoscopy
91%
Hepatocellular Carcinoma
85%
Adverse Event
81%
Endoscopic Retrograde Cholangiopancreatography
78%
Prospective Study
78%
Artificial Intelligence
78%
Bleeding
76%
Portal Hypertension
63%
Diseases
60%
Endoscopy
59%
Ribavirin
58%
Prevalence
52%
Upper Gastrointestinal Bleeding
52%
Health Care
52%
Hepatology
52%
Lenvatinib
52%
Endoscopic Ultrasound
52%
Adenoma
49%
Polyp
45%
Fine-Needle Aspiration
43%
Liver Transplantation
42%
Fibrosis
42%
Ulcer
41%
Hepatitis C
39%
Gastrointestinal Endoscopy
37%
Liver Disease
35%
Puncture
34%
Recurrent Disease
34%
Antiviral Therapy
33%
Decompensated Liver Cirrhosis
31%
Colorectal Carcinoma
29%
Colon
29%
Charlson Comorbidity Index
29%
Chronic Liver Disease
29%
Virus RNA
29%
Pancreatitis
28%
Metabolic Dysfunction-Associated Steatotic Liver Disease
28%
Cohort Analysis
28%
Odds Ratio
28%
Interferon
27%
Chronic Hepatitis C
26%
Viral Clearance
26%
Zenker's Diverticulum
26%
COVID-19
26%
Nonalcoholic Fatty Liver
26%
Cholecystectomy
26%
Pancreas Tumor
26%
Hepatitis Delta Virus
26%
Interventional Radiology
26%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Liver Cell Carcinoma
88%
Chronic Hepatitis C
69%
Ribavirin
65%
Viral Clearance
55%
Virus RNA
55%
Prevalence
54%
Hepatitis C Virus
54%
Nonalcoholic Fatty Liver
52%
Lenvatinib
52%
Colorectal Carcinoma
52%
Diseases
44%
Adverse Event
43%
Fibrosis
41%
Hepatitis C
41%
Liver Disease
40%
Pancreatitis
34%
Decompensated Liver Cirrhosis
31%
Antiviral Therapy
29%
Interferon
27%
Infection
26%
Pharmacokinetics
26%
Proton Pump Inhibitor
26%
Pibrentasvir
26%
Reducing Agent
26%
Glecaprevir
26%
Cohort Study
26%
Von Willebrand Factor
26%
Cardiovascular Disease
26%
Felty's Syndrome
26%
Selenoprotein P
26%
Recurrent Disease
26%
Pandemic
26%
Atezolizumab
26%
Hepatitis Delta Virus
26%
Cancer Mortality
26%
Bevacizumab
26%
Antivirus Agent
22%
Fatty Liver
22%
Adenoma
20%
Coronary Artery Calcification
18%
Sofosbuvir
17%
Antiviral Drug
17%
Cholestasis
13%
Ombitasvir
13%
Paritaprevir
13%
Ritonavir
13%
Dasabuvir
13%
Overall Survival
13%
Viremia
12%
